Clinical Trials Logo

Congenital Abnormalities clinical trials

View clinical trials related to Congenital Abnormalities.

Filter by:

NCT ID: NCT02952053 Completed - Clinical trials for Muscle Tone Abnormalities

Can Myotonometry Quantify Dry Needling Effectiveness on Myofascial Trigger Points?

Start date: December 12, 2015
Phase: N/A
Study type: Interventional

The main objective of this study is to assess effects of Dry Needling into Myofascial Trigger Point compared Dry Needling into Taut Band point based on the outcomes of myotnometric measurement in healthy subjects. Hypothesis: Deep Dry Needling of the latent medial Myofascial Trigger Point (MTrP) of the soleus muscle will achieve changes in myotonometric measures compared to Deep Dry Needling of the Taut Band of the soleus muscle.

NCT ID: NCT02949245 Completed - Clinical trials for Adult Spinal Deformity

Neurologic Complications in Spinal Deformity Surgery - Extension

Start date: August 17, 2017
Phase:
Study type: Observational

272 subjects with "high risk" adult spinal deformity requiring surgical correction were enrolled in the previous prospective multi-center international Scoli-RISK-1 study. "High risk" patients were defined by either their diagnoses and/or the type of surgical intervention as listed in the inclusion criteria. Neurological complications in the form of new motor and sensory deficits were monitored prospectively in all patients at hospital discharge, at 6 weeks (± 2 weeks), 6 months (± 2 months) and 24 months (± 2 months) after the surgery. The relationship to the surgical intervention was assessed in all new deficits. Regression analyses were used to evaluate the association between patient demographics, co-morbidities, treatment history, spinal deformity characteristics, surgical characteristics, non-neurologic complications and pre-surgical status to occurrence of a neurologic deficit after surgery. All enrolled Scoli-RISK-1 participants will be re-consented and asked to return for a 5 year FU visit.

NCT ID: NCT02946866 Active, not recruiting - Clinical trials for Intracerebral Hemorrhage

CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study

CHOCOOATE
Start date: June 2016
Phase:
Study type: Observational

The aim of this prospective study is to reveal the natural history of symptomatic hemorrhage in adult patients with cerebral cavernous malformation with the goal of informing the treatment plan.

NCT ID: NCT02933840 Withdrawn - Hemorrhage Clinical Trials

Using a Remote Patient Monitoring Alert System to Improve Care

Start date: January 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the efficacy of a remote patient monitoring platform and alert system in reducing adverse events for hospitalized geriatric orthopedic trauma patients.

NCT ID: NCT02928835 Completed - Clinical trials for Acquired Fixed Flexion Deformity of the Knee (Disorder)

Effects of Dynamic Splinting on Knee Flexion Angle After Total Knee Arthroplasty: A Randomized Controlled Trial

Start date: June 2011
Phase: N/A
Study type: Interventional

To evaluate the effects of a knee flexion Dynasplint orthosis on knee flexion angle after a total knee arthroplasty. Sixty participants, who underwent a total knee arthroplasty, were randomly assigned in two groups: control group and Dynasplint group.

NCT ID: NCT02920645 Enrolling by invitation - Clinical trials for Intracerebral Hemorrhage

Multicenter Validation of the AVICH Score

AVICH
Start date: September 2016
Phase: N/A
Study type: Observational

The primary objective of this multicenter study is to validate the AVICH score in terms of patient outcome prediction in AVM patients with associated ICH. Secondary objectives are the impact of pretreatment of the AVICH score. Patients outcome is measured using the modified Rankin Scale (mRS) and are grouped in favorable (mRS score, 0-2) and unfavourable (mRS score, 3-6) outcome at last follow-up (LFU). The following parameters, which are part of the AVICH score, will be compared between the 2 groups: ICH score including age, Glasgow Coma Scale (GCS) score, haemorrhage volume, presence of intraventricular hemorrhage (IVH), and localization of the ICH. Spetzler-Martin grade including AVM size, eloquent location, and venous drainage, as well as the Lawton-Young grade, including age, presence of ruptured AVM, and the nidus structure. In addition pre-/postruptured treatment modalities, including embolization, radiotherapy, surgery or no treatment will be analysed. Outcome (mRS) at 3 months, at 1 year, and at LFU will be compared. Multicentre validation study Key inclusion criteria: - All patients with ICH associated AVMs and a modified Rankin Scale <2 (so 0-1) before hemorrhage - Pretreatment (embolization, radiosurgery, surgery) before ICH is not an exclusion criteria. Key exclusion criteria: - incomplete data set - AVM Patients with only subarachnoid hemorrhage (SAH) or IVH and no ICH

NCT ID: NCT02918344 Recruiting - Infection Clinical Trials

Complications From the Use of Calcium Phosphate Paste in Mandibular Lengthening Osteotomies

Start date: March 1, 2017
Phase:
Study type: Observational

The goal of this study is to determine if the use of calcium phosphate paste in mandibular lengthening surgery causes more complications as surgical site infections and hardware removal. An evaluation will be made to determine if the benefits of the use of the paste (3D-stability, prevention of early relapse and unaesthetic indentation) outweighs the disadvantages.

NCT ID: NCT02914171 Completed - Ebstein Anomaly Clinical Trials

Study of Autologous Bone Marrow Derived Mononuclear Cells for Treatment of Ebstein Anomaly

Ebstein
Start date: September 2016
Phase: Phase 1
Study type: Interventional

The objective of this study is to determine the safety and feasibility of autologous mononuclear cells (MNS) collected from bone marrow (BM) and using an add-on intramyocardial delivery for individuals with Ebstein anomaly undergoing surgical intervention compared to the control group undergoing the same surgical procedure without cell delivery. This add-on procedure has the potential to foster a new strategy for individuals with congenital heart disease.This is an open-label study of autologous MNC derived from bone marrow with a 2-year follow-up to document 1) incidence and severity of adverse event and 2) monitor changes in cardiac structure and function.

NCT ID: NCT02896881 Recruiting - Clinical trials for Brain Arteriovenous Malformations

Interest of New MRI Sequences After Embolization of Brain Arteriovenous Malformations

MAV-IRM
Start date: February 1, 2017
Phase:
Study type: Observational

In previous studies exploring specific sequences of MRI (susceptibility weighted imaging (SWI) and arterial spin labeling (ASL)), the investigators have shown the great sensibility of these MRI sequences to detect arteriovenous shunts, compared to angiography imaging (static or dynamic). This prospective study aims to compare multisequence MRI to brain arteriography imaging in patients undergoing brain arteriovenous malformations embolization.

NCT ID: NCT02890641 Recruiting - Tuberous Sclerosis Clinical Trials

Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies

GENEPHY
Start date: December 12, 2015
Phase:
Study type: Observational

Brain somatic mutations in genes belonging to the mTOR signaling pathway are a frequent cause of cortical malformations, including focal cortical dysplasia or hemimegalencephaly. The present study aims to search for brain somatic mutations in paired blood-brain samples and perform functional validation in children with drug-resistant focal epilepsy